diabetes. Type 2 diabetes mellitus with diabetic neuropathy, unspecified
Conditions
Interventions
Intervention 1: Intervention group: People in this group will receive diabetic prevention shoes with customized diabetic insoles and will use them for 3 months. The shoes will be made based on the siz
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 65-45 years Diagnosis of diabetic neuropathy by an endocrinologist based on the Michigan Neuropathy Screening Scale A history of type 2 diabetes for at least 5 years Pressure distribution of more than 200 kPa on the head of metatarsals Ability to walk and stand independently without aids Ability to withstand weight and pressure on the floor surface No pain in the soles of the feet Do not use diabetic shoes and insoles in the past year Have a normal BMI Fasting blood sugar above 125 HBA1C between 7 and 9 Risk factor one based on IWGDF classification Employees who work outside the home for at least 6 hours a day. Ordinary people's shoes are in the Oxford category
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transepidermal water loss. Timepoint: Initially and 3 months after onset. Method of measurement: Multi Probe Adapter System MPA 10 (Tewameter probe). | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin elasticity. Timepoint: Initially and 3 months after onset. Method of measurement: Cutometer MPA580.;Thickness of the hypodermis. Timepoint: Initially and 3 months after onset. Method of measurement: Skin scanner-DUB. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHassan Saeedi
Iran University of Medical Sciences
Outcome results
None listed